Free Trial

Treace Medical Concepts (TMCI) Competitors

Treace Medical Concepts logo
$7.19 +0.15 (+2.13%)
Closing price 09/18/2025 04:00 PM Eastern
Extended Trading
$7.20 +0.00 (+0.07%)
As of 09/18/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TMCI vs. CNMD, NVCR, SSII, CDRE, BLFS, ESTA, MDXG, PLSE, INMD, and IRMD

Should you be buying Treace Medical Concepts stock or one of its competitors? The main competitors of Treace Medical Concepts include CONMED (CNMD), NovoCure (NVCR), SS Innovations International (SSII), Cadre (CDRE), BioLife Solutions (BLFS), Establishment Labs (ESTA), MiMedx Group (MDXG), Pulse Biosciences (PLSE), InMode (INMD), and iRadimed (IRMD). These companies are all part of the "medical equipment" industry.

Treace Medical Concepts vs. Its Competitors

CONMED (NYSE:CNMD) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, media sentiment, analyst recommendations, earnings, risk and institutional ownership.

84.1% of Treace Medical Concepts shares are owned by institutional investors. 3.1% of CONMED shares are owned by company insiders. Comparatively, 27.7% of Treace Medical Concepts shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

CONMED currently has a consensus target price of $59.80, suggesting a potential upside of 16.16%. Treace Medical Concepts has a consensus target price of $9.83, suggesting a potential upside of 36.76%. Given Treace Medical Concepts' stronger consensus rating and higher possible upside, analysts plainly believe Treace Medical Concepts is more favorable than CONMED.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CONMED
0 Sell rating(s)
4 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.20
Treace Medical Concepts
0 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

In the previous week, CONMED had 6 more articles in the media than Treace Medical Concepts. MarketBeat recorded 7 mentions for CONMED and 1 mentions for Treace Medical Concepts. Treace Medical Concepts' average media sentiment score of 1.87 beat CONMED's score of 0.59 indicating that Treace Medical Concepts is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CONMED
4 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Treace Medical Concepts
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

CONMED has a net margin of 8.31% compared to Treace Medical Concepts' net margin of -23.01%. CONMED's return on equity of 14.43% beat Treace Medical Concepts' return on equity.

Company Net Margins Return on Equity Return on Assets
CONMED8.31% 14.43% 6.05%
Treace Medical Concepts -23.01%-46.76%-23.35%

CONMED has a beta of 1.18, indicating that its share price is 18% more volatile than the S&P 500. Comparatively, Treace Medical Concepts has a beta of 0.71, indicating that its share price is 29% less volatile than the S&P 500.

CONMED has higher revenue and earnings than Treace Medical Concepts. Treace Medical Concepts is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CONMED$1.31B1.22$132.42M$3.5314.58
Treace Medical Concepts$209.36M2.17-$55.74M-$0.79-9.10

Summary

CONMED beats Treace Medical Concepts on 9 of the 16 factors compared between the two stocks.

Get Treace Medical Concepts News Delivered to You Automatically

Sign up to receive the latest news and ratings for TMCI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TMCI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TMCI vs. The Competition

MetricTreace Medical ConceptsMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$444.74M$6.81B$5.76B$10.28B
Dividend YieldN/A1.21%5.74%4.63%
P/E Ratio-9.1027.0876.8626.97
Price / Sales2.17198.85543.77128.80
Price / CashN/A21.6337.1760.63
Price / Book3.975.0313.836.37
Net Income-$55.74M$178.07M$3.29B$271.46M
7 Day Performance-3.36%5.59%0.93%2.35%
1 Month Performance2.13%8.50%5.31%7.78%
1 Year Performance31.20%19.34%84.25%32.27%

Treace Medical Concepts Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TMCI
Treace Medical Concepts
2.7533 of 5 stars
$7.19
+2.1%
$9.83
+36.8%
+31.2%$444.74M$209.36M-9.10250Positive News
CNMD
CONMED
4.342 of 5 stars
$53.78
-2.2%
$59.80
+11.2%
-32.3%$1.70B$1.31B15.233,900Ex-Dividend
Insider Trade
NVCR
NovoCure
4.2546 of 5 stars
$12.60
+2.6%
$28.79
+128.5%
-26.2%$1.37B$605.22M-8.081,488Positive News
Gap Up
SSII
SS Innovations International
N/A$6.14
-12.3%
N/AN/A$1.36B$20.65M0.004News Coverage
Gap Up
High Trading Volume
CDRE
Cadre
2.5708 of 5 stars
$31.83
-0.5%
$31.50
-1.0%
-6.0%$1.30B$567.56M33.862,284Positive News
BLFS
BioLife Solutions
2.5265 of 5 stars
$26.22
-0.9%
$31.29
+19.3%
+10.8%$1.27B$93.47M-218.48440Positive News
ESTA
Establishment Labs
2.4696 of 5 stars
$38.24
-2.0%
$56.50
+47.8%
-4.2%$1.13B$166.02M-12.541,018Positive News
MDXG
MiMedx Group
3.5235 of 5 stars
$7.17
+0.4%
$12.00
+67.4%
+15.7%$1.06B$348.88M34.14870Positive News
PLSE
Pulse Biosciences
4.1305 of 5 stars
$15.04
-0.5%
$22.00
+46.3%
-2.4%$1.02B$700K-14.32140News Coverage
Positive News
Insider Trade
Gap Up
INMD
InMode
2.9574 of 5 stars
$15.28
+2.0%
$18.04
+18.1%
-13.1%$946.87M$401.56M6.19480Positive News
IRMD
iRadimed
4.7948 of 5 stars
$71.85
-0.2%
$72.00
+0.2%
+49.4%$915.36M$73.24M44.35110News Coverage
Positive News
Insider Trade
Short Interest ↓

Related Companies and Tools


This page (NASDAQ:TMCI) was last updated on 9/19/2025 by MarketBeat.com Staff
From Our Partners